EC
EntryPoint Capital Portfolio holdings
AUM
$200M
1-Year Return
6.93%
This Quarter Return
+2.29%
1 Year Return
+6.93%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$4.02M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
513
Increased
412
Reduced
455
Closed
458
Top Buys
| 1 |
Unisys
UIS
|
+$454K |
| 2 |
Sutro Biopharma
STRO
|
+$394K |
| 3 |
Agilysys
AGYS
|
+$382K |
| 4 |
Schrodinger
SDGR
|
+$371K |
| 5 |
REV Group
REVG
|
+$345K |
Top Sells
| 1 |
NextDecade
NEXT
|
+$643K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
B. Riley Financial
RILY
|
+$524K |
| 4 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
| 5 |
Taysha Gene Therapies
TSHA
|
+$484K |
Sector Composition
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.08% |
| 3 | Technology | 16.88% |
| 4 | Financials | 12.63% |
| 5 | Consumer Discretionary | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Vericel Corp
VCEL
$1.64B
| $96.1K | 0.09% |
1,848
-4,980
| -73% | -$259K |
|
452
Universal Insurance Holdings
UVE
$703M
| $96K | 0.09% |
4,724
-1,366
| -22% | -$27.8K |
|
453
Aris Water Solutions
ARIS
$778M
| $95.9K | 0.09% |
6,780
-21,421
| -76% | -$303K |
|
454
Bloomin' Brands
BLMN
$588M
| $95.9K | 0.09% |
3,343
+3,292
| +6,455% | +$94.4K |
|
455
PG&E
PCG
$32.9B
| $95.4K | 0.09% |
+5,695
| New | +$95.4K |
|
456
Argan
AGX
$3B
| $94.9K | 0.09% |
+1,877
| New | +$94.9K |
|
457
Host Hotels & Resorts
HST
$12B
| $94.7K | 0.08% |
+4,579
| New | +$94.7K |
|
458
Nicolet Bankshares
NIC
$2.01B
| $94.7K | 0.08% |
1,101
+543
| +97% | +$46.7K |
|
459
Chemed
CHE
$6.74B
| $94.4K | 0.08% |
147
+18
| +14% | +$11.6K |
|
460
Extreme Networks
EXTR
$2.92B
| $94.3K | 0.08% |
8,173
-72
| -0.9% | -$831 |
|
461
M/I Homes
MHO
$4.04B
| $94.3K | 0.08% |
692
+326
| +89% | +$44.4K |
|
462
Jacobs Solutions
J
$17.2B
| $94.2K | 0.08% |
741
+18
| +2% | +$2.29K |
|
463
Insperity
NSP
$2.01B
| $94.2K | 0.08% |
859
+534
| +164% | +$58.5K |
|
464
Immunovant
IMVT
$2.86B
| $94.1K | 0.08% |
2,912
+2,163
| +289% | +$69.9K |
|
|
SMAR
465
DELISTED
Smartsheet Inc.
SMAR
| $93.6K | 0.08% |
2,432
+821
| +51% | +$31.6K |
|
466
Voyager Therapeutics
VYGR
$222M
| $93.5K | 0.08% |
10,039
-10,684
| -52% | -$99.5K |
|
467
Cardinal Health
CAH
$36B
| $93.4K | 0.08% |
+835
| New | +$93.4K |
|
468
AdaptHealth
AHCO
$1.25B
| $93.3K | 0.08% |
8,109
-35,371
| -81% | -$407K |
|
469
Plexus
PLXS
$3.68B
| $92.5K | 0.08% |
976
+351
| +56% | +$33.3K |
|
470
Symbotic
SYM
$5.4B
| $92.5K | 0.08% |
2,055
-3,293
| -62% | -$148K |
|
|
JBIO
471
Jade Biosciences, Inc. Common Stock
JBIO
$249M
| $92.4K | 0.08% |
89
-86
| -49% | -$89.3K |
|
472
Nucor
NUE
$32.4B
| $92.4K | 0.08% |
467
+144
| +45% | +$28.5K |
|
473
KalVista Pharmaceuticals
KALV
$786M
| $92.3K | 0.08% |
+7,784
| New | +$92.3K |
|
474
Ironwood Pharmaceuticals
IRWD
$180M
| $92.2K | 0.08% |
10,589
+8,874
| +517% | +$77.3K |
|
|
NXRT
475
NexPoint Residential Trust
NXRT
$865M
| $91.9K | 0.08% |
2,855
-3,233
| -53% | -$104K |
|